SCHEMBL982273

SCHEMBL982273

CCCc1cccc(O)c1-c1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.45
CTSG P08311 1/20 0.45
HTR1A P08908 1/20 0.43
BID P55957 3/20 0.41
MCL1 Q07820 3/20 0.41
BCL2L1 Q07817 2/20 0.41
BAK1 Q16611 2/20 0.41
KAT8 Q9H7Z6 2/20 0.41
PPARG P37231 1/20 0.41
PPARA Q07869 1/20 0.41
EP300 Q09472 1/20 0.41
KAT2A Q92830 1/20 0.41
KAT2B Q92831 1/20 0.41
KAT5 Q92993 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
IAPP P10997 2/20 0.40
HSPA5 P11021 1/20 0.39
TAAR1 Q96RJ0 1/20 0.38
AKR1B1 P15121 1/20 0.38
ESR1 P03372 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL548499 0.89 BID (0.50) ELANECTSGBIDMCL1BCL2L1
SCHEMBL11830553 0.88 BID (0.49) ELANECTSGBIDMCL1BCL2L1
SCHEMBL324187 0.88 BID (0.49) ELANECTSGBIDMCL1BCL2L1
SCHEMBL983846 0.88 BID (0.56) ELANECTSGBIDMCL1BCL2L1
SCHEMBL984109 0.86 BID (0.59) ELANECTSGBIDMCL1BCL2L1
SCHEMBL27632134 0.86 ELANE (0.48) ELANECTSGHTR1ABIDMCL1
SCHEMBL27929099 0.86 BID (0.59) ELANECTSGBIDMCL1BCL2L1
SCHEMBL983932 0.86 BID (0.59) ELANECTSGBIDMCL1BCL2L1
SCHEMBL981892 0.86 BID (0.59) ELANECTSGBIDMCL1BCL2L1
SCHEMBL983657 0.86 BID (0.59) ELANECTSGBIDMCL1BCL2L1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115779493-A Method for purifying liquid crystal monomer or liquid crystal composition by using functionalized silica gel material 苏州硒诺唯新新材料科技有限公司 2023-03-14 CN disclosed
EP-2275405-B1 PROCESS FOR PRODUCING ISOCYANATE USING DIARYL CARBONATE ASAHI CHEMICAL IND (JP) 2019-04-24 EP disclosed
CN-103988127-B Photosensitive resin composition, method for producing cured relief pattern, semiconductor device, and display device 旭化成株式会社 2019-04-19 CN disclosed
EP-2275406-B1 PROCESS FOR PRODUCING ISOCYANATE ASAHI CHEMICAL IND (JP) 2018-11-28 EP disclosed
CN-108676253-A Light-high-strength display/panel bracket and preparation method thereof 安徽尚游文化传媒有限公司 2018-10-19 CN disclosed
CN-105246940-B Optical semiconductor sealing solidification compound 株式会社大赛璐 2018-09-04 CN disclosed
CN-108373856-A Lamilate and pattern forming method 信越化学工业株式会社 2018-08-07 CN disclosed
EP-2792673-B1 Carbamic acid ester derivatives for the production of isocyanate and aromatic hydroxy compounds ASAHI CHEMICAL IND (JP) 2018-07-25 EP disclosed
CN-107957657-A Membrane material and pattern formation method 信越化学工业株式会社 2018-04-24 CN disclosed
CN-105419219-B Low hair dirt toner 住友电木株式会社 2018-04-03 CN disclosed
US-20100113823-A1 ISOCYANATE PRODUCTION PROCESS USING COMPOSITION CONTAINING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSFER AND STORAGE OF CARBAMIC ACID ESTER ASAHI KASEI CHEMICALS CORPORATION (JP) 2010-05-06 US disclosed
EP-2147909-A1 METHOD FOR PRODUCTION OF ISOCYANATE USING COMPOSITION COMPRISING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSPORT OR STORAGE OF CARBAMIC ACID ESTER Asahi Kasei Chemicals Corporation (JP) 2010-01-27 EP disclosed
US-4157324-A High ortho etherified resole resins admixed with coreactive resins MONSANTO COMPANY (US) 1979-06-05 US disclosed
US-4122235-A LAMINATE, METAL SALT CURING ACCELERATOR MONSANTO COMPANY (US) 1978-10-24 US disclosed
US-4122054-A High ortho etherified resole resins MONSANTO COMPANY (US) 1978-10-24 US disclosed
US-4120847-A High ortho etherified resole resins MONSANTO COMPANY (US) 1978-10-17 US disclosed
US-4112188-A LAMINATE, BORIC ACID, DIAMMONIUM TETRABORATE, DIAMMONIUM PENTABORATE, AND/OR DIAMMONIUM OCTABORATE AS ACCELERATORS MONSANTO COMPANY (US) 1978-09-05 US disclosed
US-4045398-A BORON COMPOUND CURING ACCELERATOR MONSANTO COMPANY (US) 1977-08-30 US disclosed
US-4043970-A IMPROVED CURE RATE IN ELECTRICAL LAMINATES MONSANTO COMPANY (US) 1977-08-23 US disclosed
US-4022942-A NOVOLAKS OR B-STAGE RESINS MONSANTO COMPANY (US) 1977-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113823-A1 ISOCYANATE PRODUCTION PROCESS USING COMPOSITION CONTAINING CARBAMIC ACID ESTER AND AROMATIC HYDROXY COMPOUND, AND COMPOSITION FOR TRANSFER AND STORAGE OF CARBAMIC ACID ESTER PAH, APEH, CPS1 ELANE 1749/4885CTSG 158/4885HTR1A 2960/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.